Research / DAKT / Fundamental state Inspectable configuration
State dimensions Filing 0000915779-23-000133 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
28.38% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.35% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.57% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
6.36% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
71.05% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
27.19% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
9.75% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.63% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 61 states Self-history eligible
Oct 30, 2021 8/8 normalized Level 3 Jan 29, 2022 8/8 normalized Level 3 Apr 30, 2022 8/8 normalized Level 3 Jul 30, 2022 8/8 normalized Level 3 Oct 29, 2022 8/8 normalized Level 3 Jan 28, 2023 8/8 normalized Level 3 Apr 29, 2023 8/8 normalized Level 3 Jul 29, 2023 8/9 normalized Level 3 Oct 28, 2023 8/9 normalized Level 3 Jan 27, 2024 8/9 normalized Level 3 Apr 27, 2024 8/9 normalized Level 3 Jul 27, 2024 8/9 normalized Level 3 Oct 26, 2024 8/9 normalized Level 3 Jan 25, 2025 8/9 normalized Level 3 Apr 26, 2025 8/9 normalized Level 3 Aug 2, 2025 9/9 normalized Level 3 Nov 1, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 May 2, 2026 9/9 normalized Level 3 Aug 1, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 18.46%
Current 28.38%
Delta 9.92% Capex Intensity Increased
Previous 1.96%
Current 2.35%
Delta 0.39% Cash Generation Increased
Previous 8.28%
Current 12.57%
Delta 4.29% Growth Decreased
Previous 35.26%
Current 6.36%
Delta -28.89% Inventory Pressure Increased
Previous 62.27%
Current 71.05%
Delta 8.78% Margin Decreased
Previous 30.60%
Current 27.19%
Delta -3.41% Profitability Decreased
Previous 17.29%
Current 9.75%
Delta -7.55% R And D Intensity Increased
Previous 3.61%
Current 4.63%
Delta 1.01% Sbc Intensity Increased
Previous 0.24%
Current 0.27%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.